Truist analyst Peter Osterland lowered the firm’s price target on Westlake (WLK) to $92 from $117 and keeps a Buy rating on the shares. The firm is reducing its FY25 adjusted EBITDA view to $1.53B from $1.92B, driven by lower expected earnings within the commodity chemical PEM – Performance and Essential Materials – segment, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK: